Phase 1 Study of Anticancer Drug in Patients With Tumors
Medindia,
Three patients had partial responses and 8 had prolonged stable disease; 44.4% of patients at dose levels 6-8 achieved one of…
Oncotarget publishes Phase 1 study of Z-Endoxifen in patients with advanced cancers
The Medical News,
Oncotarget published " Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive…
Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors | Scienmag: Latest Science and Health News
ScienMag,
The Oncotarget article provides evidence that antitumor activity and prolonged stable disease are achieved with Z-endoxifen…
Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors
Bioengineer.org,
The Oncotarget article provides evidence that antitumor activity and prolonged stable disease are achieved with Z-endoxifen…
Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors
EurekAlert!,
Oncotarget published "Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive…